Topic: Salim Abdool Karim
Trials of microbicide gels to protect women against HIV infection have a perfect record--not one of them has worked, and some were even harmful. As reported here today at the 16th Conference on Retroviruses and Opportunistic Infections, the study showed that a ...
A widely anticipated presentation here at the 18th International AIDS Conference turned out to be doubly sweet. Quarraisha and Salim Abdool Karim, the husband-and-wife team who led the study, called CAPRISA 004, presented the bulk of the data during an afternoon session ...
A vaginal gel applied consistently before and after sex reduced the risk of HIV infection by more than half, according to a study presented Monday at the International AIDS Conference in Vienna.. Despite these promising results, the gel still needs to be ...
A widely anticipated presentation here at the 18th International AIDS Conference turned out to be doubly sweet. Quarraisha and Salim Abdool Karim, the husband-and-wife team who led the study, called CAPRISA 004, presented the bulk of the data during an afternoon session ...
A vaginal gel applied consistently before and after sex reduced the risk of HIV infection by more than half, according to a study presented Monday at the International AIDS Conference in Vienna.. Despite these promising results, the gel still needs to be ...
Scientists on Monday reported a major stride towards a vaginal gel that can thwart HIV, a goal that would be of huge benefit to African women bearing the brunt of the AIDS pandemic.A prototype cream tested in South Africa reduced risk of ...
WASHINGTON (Reuters) - A protective gel made using Gilead Sciences Inc's HIV drug tenofovir reduced HIV infections in women by 39 percent over two and a half years -- the first time such an approach has protected against the AIDS virus, South ...
A vaginal microbicide can cut HIV infection rates by 39 percent in women, researchers announced Monday. It was tested, starting in 2007, in a double-blind, randomized controlled trial of 889 sexually active women ages 18 to 40, in the KwaZulu-Natal province, which ...
US company's AIDS-fighting gel for women offers some hope in preliminary five-country studyAn experimental vaginal gel has shown some promise in preventing infection from the AIDS virus the first study to offer hope that a microbicide may soon join the medical arsenal ...